 | • レポートコード：D0GIR-02728 • 出版社/出版日：GlobalInfoResearch / 2020年9月30日 ※2024年版があります。お問い合わせください。 • レポート形態：英文、PDF、103ページ • 納品方法：Eメール • 産業分類：医療、製薬、バイオ |
| Single User | ￥515,040 (USD3,480) | ▷ お問い合わせ |
| Multi User | ￥772,560 (USD5,220) | ▷ お問い合わせ |
| Corporate User | ￥1,030,080 (USD6,960) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| 本調査レポートでは、炎症性腸疾患（IBD）治療の世界市場を広く調査・分析し、今後の市場展望をまとめております。炎症性腸疾患（IBD）治療の種類別市場規模（TNF阻害剤、アミノサリチル酸、免疫調節剤、コルチコステロイド）、用途別市場規模（病院薬局、小売薬局、オンライン薬局）、地域別市場規模（北米、アメリカ、ヨーロッパ、アジア、中国、日本、東南アジア、南米、中東、アフリカなど）、市場動向、企業別販売量と市場シェアなどの情報を掲載しています。 ・市場概要 ・企業情報（販売量、市場シェア、製品概要、SWOT分析）：AbbVie、Novartis、Janssen Biotech, Inc. (Johnson & Johnson)、Pfizer、Takeda Pharmaceutical、Takeda、Bausch Health、Allergan、Biogen Inc. ・地域別グローバル市場分析 2015年-2020年 ・炎症性腸疾患（IBD）治療の北米市場（アメリカ、カナダ、メキシコ） ・炎症性腸疾患（IBD）治療のヨーロッパ市場（ドイツ、イギリス、フランス、ロシア、イタリア） ・炎症性腸疾患（IBD）治療のアジア市場（中国、日本、韓国、インド、東南アジア、オーストラリア） ・炎症性腸疾患（IBD）治療の南米市場（ブラジル、アルゼンチン） ・炎症性腸疾患（IBD）治療の中東・アフリカ市場（サウジアラビア、トルコ、エジプト、南アフリカ） ・種類別分析：TNF阻害剤、アミノサリチル酸、免疫調節剤、コルチコステロイド ・用途別分析：病院薬局、小売薬局、オンライン薬局 ・地域別市場規模予測 2021年-2025年 ・調査の結果・結論 |
Market Overview
The global Inflammatory Bowel Disease (IBD) Treatment market size is expected to gain market growth in the forecast period of 2020 to 2025, with a CAGR of 2.2% in the forecast period of 2020 to 2025 and will expected to reach USD 14950 million by 2025, from USD 13690 million in 2019.
The Inflammatory Bowel Disease (IBD) Treatment market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade regulations, recent developments, opportunities analysis, strategic market growth analysis, product launches, area marketplace expanding, and technological innovations.
Market segmentation
Inflammatory Bowel Disease (IBD) Treatment market is split by Type and by Application. For the period 2015-2025, the growth among segments provide accurate calculations and forecasts for sales by Type and by Application in terms of volume and value. This analysis can help you expand your business by targeting qualified niche markets.
By Type, Inflammatory Bowel Disease (IBD) Treatment market has been segmented into:
TNF Inhibitors
Aminosalicyclates
Immunomodulators
Corticosteroids
By Application, Inflammatory Bowel Disease (IBD) Treatment has been segmented into:
Hospital Pharmacy
Retail Pharmacy
Online Pharmacy
Regions and Countries Level Analysis
Regional analysis is another highly comprehensive part of the research and analysis study of the global Inflammatory Bowel Disease (IBD) Treatment market presented in the report. This section sheds light on the sales growth of different regional and country-level Inflammatory Bowel Disease (IBD) Treatment markets. For the historical and forecast period 2015 to 2025, it provides detailed and accurate country-wise volume analysis and region-wise market size analysis of the global Inflammatory Bowel Disease (IBD) Treatment market.
The report offers in-depth assessment of the growth and other aspects of the Inflammatory Bowel Disease (IBD) Treatment market in important countries (regions), including:
North America (United States, Canada and Mexico)
Europe (Germany, France, UK, Russia and Italy)
Asia-Pacific (China, Japan, Korea, India, Southeast Asia and Australia)
South America (Brazil, Argentina, Colombia)
Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa)
Competitive Landscape and Inflammatory Bowel Disease (IBD) Treatment Market Share Analysis
Inflammatory Bowel Disease (IBD) Treatment competitive landscape provides details by vendors, including company overview, company total revenue (financials), market potential, global presence, Inflammatory Bowel Disease (IBD) Treatment sales and revenue generated, market share, price, production sites and facilities, SWOT analysis, product launch. For the period 2015-2020, this study provides the Inflammatory Bowel Disease (IBD) Treatment sales, revenue and market share for each player covered in this report.
The major players covered in Inflammatory Bowel Disease (IBD) Treatment are:
AbbVie
Novartis
Janssen Biotech, Inc. (Johnson & Johnson)
Pfizer
Takeda Pharmaceutical
Takeda
Bausch Health
Allergan
Biogen Inc.
Table of Contents
1 Inflammatory Bowel Disease (IBD) Treatment Market Overview
1.1 Product Overview and Scope of Inflammatory Bowel Disease (IBD) Treatment
1.2 Classification of Inflammatory Bowel Disease (IBD) Treatment by Type
1.2.1 Global Inflammatory Bowel Disease (IBD) Treatment Revenue by Type: 2015 VS 2019 VS 2025
1.2.2 Global Inflammatory Bowel Disease (IBD) Treatment Revenue Market Share by Type in 2019
1.2.3 TNF Inhibitors
1.2.4 Aminosalicyclates
1.2.5 Immunomodulators
1.2.6 Corticosteroids
1.3 Global Inflammatory Bowel Disease (IBD) Treatment Market by Application
1.3.1 Overview: Global Inflammatory Bowel Disease (IBD) Treatment Revenue by Application: 2015 VS 2019 VS 2025
1.3.2 Hospital Pharmacy
1.3.3 Retail Pharmacy
1.3.4 Online Pharmacy
1.4 Global Inflammatory Bowel Disease (IBD) Treatment Market by Regions
1.4.1 Global Inflammatory Bowel Disease (IBD) Treatment Market Size by Regions: 2015 VS 2019 VS 2025
1.4.2 Global Market Size of Inflammatory Bowel Disease (IBD) Treatment (2015-2025)
1.4.3 North America (USA, Canada and Mexico) Inflammatory Bowel Disease (IBD) Treatment Status and Prospect (2015-2025)
1.4.4 Europe (Germany, France, UK, Russia and Italy) Inflammatory Bowel Disease (IBD) Treatment Status and Prospect (2015-2025)
1.4.5 Asia-Pacific (China, Japan, Korea, India and Southeast Asia) Inflammatory Bowel Disease (IBD) Treatment Status and Prospect (2015-2025)
1.4.6 South America (Brazil, Argentina, Colombia) Inflammatory Bowel Disease (IBD) Treatment Status and Prospect (2015-2025)
1.4.7 Middle East & Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa) Inflammatory Bowel Disease (IBD) Treatment Status and Prospect (2015-2025)
2 Company Profiles
2.1 AbbVie
2.1.1 AbbVie Details
2.1.2 AbbVie Major Business and Total Revenue (Financial Highlights) Analysis
2.1.3 AbbVie SWOT Analysis
2.1.4 AbbVie Product and Services
2.1.5 AbbVie Inflammatory Bowel Disease (IBD) Treatment Revenue, Gross Margin and Market Share (2018-2019)
2.2 Novartis
2.2.1 Novartis Details
2.2.2 Novartis Major Business and Total Revenue (Financial Highlights) Analysis
2.2.3 Novartis SWOT Analysis
2.2.4 Novartis Product and Services
2.2.5 Novartis Inflammatory Bowel Disease (IBD) Treatment Revenue, Gross Margin and Market Share (2018-2019)
2.3 Janssen Biotech, Inc. (Johnson & Johnson)
2.3.1 Janssen Biotech, Inc. (Johnson & Johnson) Details
2.3.2 Janssen Biotech, Inc. (Johnson & Johnson) Major Business and Total Revenue (Financial Highlights) Analysis
2.3.3 Janssen Biotech, Inc. (Johnson & Johnson) SWOT Analysis
2.3.4 Janssen Biotech, Inc. (Johnson & Johnson) Product and Services
2.3.5 Janssen Biotech, Inc. (Johnson & Johnson) Inflammatory Bowel Disease (IBD) Treatment Revenue, Gross Margin and Market Share (2018-2019)
2.4 Pfizer
2.4.1 Pfizer Details
2.4.2 Pfizer Major Business and Total Revenue (Financial Highlights) Analysis
2.4.3 Pfizer SWOT Analysis
2.4.4 Pfizer Product and Services
2.4.5 Pfizer Inflammatory Bowel Disease (IBD) Treatment Revenue, Gross Margin and Market Share (2018-2019)
2.5 Takeda Pharmaceutical
2.5.1 Takeda Pharmaceutical Details
2.5.2 Takeda Pharmaceutical Major Business and Total Revenue (Financial Highlights) Analysis
2.5.3 Takeda Pharmaceutical SWOT Analysis
2.5.4 Takeda Pharmaceutical Product and Services
2.5.5 Takeda Pharmaceutical Inflammatory Bowel Disease (IBD) Treatment Revenue, Gross Margin and Market Share (2018-2019)
2.6 Takeda
2.6.1 Takeda Details
2.6.2 Takeda Major Business and Total Revenue (Financial Highlights) Analysis
2.6.3 Takeda SWOT Analysis
2.6.4 Takeda Product and Services
2.6.5 Takeda Inflammatory Bowel Disease (IBD) Treatment Revenue, Gross Margin and Market Share (2018-2019)
2.7 Bausch Health
2.7.1 Bausch Health Details
2.7.2 Bausch Health Major Business and Total Revenue (Financial Highlights) Analysis
2.7.3 Bausch Health SWOT Analysis
2.7.4 Bausch Health Product and Services
2.7.5 Bausch Health Inflammatory Bowel Disease (IBD) Treatment Revenue, Gross Margin and Market Share (2018-2019)
2.8 Allergan
2.8.1 Allergan Details
2.8.2 Allergan Major Business and Total Revenue (Financial Highlights) Analysis
2.8.3 Allergan SWOT Analysis
2.8.4 Allergan Product and Services
2.8.5 Allergan Inflammatory Bowel Disease (IBD) Treatment Revenue, Gross Margin and Market Share (2018-2019)
2.9 Biogen Inc.
2.9.1 Biogen Inc. Details
2.9.2 Biogen Inc. Major Business and Total Revenue (Financial Highlights) Analysis
2.9.3 Biogen Inc. SWOT Analysis
2.9.4 Biogen Inc. Product and Services
2.9.5 Biogen Inc. Inflammatory Bowel Disease (IBD) Treatment Revenue, Gross Margin and Market Share (2018-2019)
3 Market Competition, by Players
3.1 Global Inflammatory Bowel Disease (IBD) Treatment Revenue and Share by Players (2015-2020)
3.2 Market Concentration Rate
3.2.1 Top 5 Inflammatory Bowel Disease (IBD) Treatment Players Market Share
3.2.2 Top 10 Inflammatory Bowel Disease (IBD) Treatment Players Market Share
3.3 Market Competition Trend
4 Market Size by Regions
4.1 Global Inflammatory Bowel Disease (IBD) Treatment Revenue and Market Share by Regions
4.2 North America Inflammatory Bowel Disease (IBD) Treatment Revenue and Growth Rate (2015-2020)
4.3 Europe Inflammatory Bowel Disease (IBD) Treatment Revenue and Growth Rate (2015-2020)
4.4 Asia-Pacific Inflammatory Bowel Disease (IBD) Treatment Revenue and Growth Rate (2015-2020)
4.5 South America Inflammatory Bowel Disease (IBD) Treatment Revenue and Growth Rate (2015-2020)
4.6 Middle East & Africa Inflammatory Bowel Disease (IBD) Treatment Revenue and Growth Rate (2015-2020)
5 North America Inflammatory Bowel Disease (IBD) Treatment Revenue by Countries
5.1 North America Inflammatory Bowel Disease (IBD) Treatment Revenue by Countries (2015-2020)
5.2 USA Inflammatory Bowel Disease (IBD) Treatment Revenue and Growth Rate (2015-2020)
5.3 Canada Inflammatory Bowel Disease (IBD) Treatment Revenue and Growth Rate (2015-2020)
5.4 Mexico Inflammatory Bowel Disease (IBD) Treatment Revenue and Growth Rate (2015-2020)
6 Europe Inflammatory Bowel Disease (IBD) Treatment Revenue by Countries
6.1 Europe Inflammatory Bowel Disease (IBD) Treatment Revenue by Countries (2015-2020)
6.2 Germany Inflammatory Bowel Disease (IBD) Treatment Revenue and Growth Rate (2015-2020)
6.3 UK Inflammatory Bowel Disease (IBD) Treatment Revenue and Growth Rate (2015-2020)
6.4 France Inflammatory Bowel Disease (IBD) Treatment Revenue and Growth Rate (2015-2020)
6.5 Russia Inflammatory Bowel Disease (IBD) Treatment Revenue and Growth Rate (2015-2020)
6.6 Italy Inflammatory Bowel Disease (IBD) Treatment Revenue and Growth Rate (2015-2020)
7 Asia-Pacific Inflammatory Bowel Disease (IBD) Treatment Revenue by Countries
7.1 Asia-Pacific Inflammatory Bowel Disease (IBD) Treatment Revenue by Countries (2015-2020)
7.2 China Inflammatory Bowel Disease (IBD) Treatment Revenue and Growth Rate (2015-2020)
7.3 Japan Inflammatory Bowel Disease (IBD) Treatment Revenue and Growth Rate (2015-2020)
7.4 Korea Inflammatory Bowel Disease (IBD) Treatment Revenue and Growth Rate (2015-2020)
7.5 India Inflammatory Bowel Disease (IBD) Treatment Revenue and Growth Rate (2015-2020)
7.6 Southeast Asia Inflammatory Bowel Disease (IBD) Treatment Revenue and Growth Rate (2015-2020)
8 South America Inflammatory Bowel Disease (IBD) Treatment Revenue by Countries
8.1 South America Inflammatory Bowel Disease (IBD) Treatment Revenue by Countries (2015-2020)
8.2 Brazil Inflammatory Bowel Disease (IBD) Treatment Revenue and Growth Rate (2015-2020)
8.3 Argentina Inflammatory Bowel Disease (IBD) Treatment Revenue and Growth Rate (2015-2020)
9 Middle East & Africa Revenue Inflammatory Bowel Disease (IBD) Treatment by Countries
9.1 Middle East & Africa Inflammatory Bowel Disease (IBD) Treatment Revenue by Countries (2015-2020)
9.2 Saudi Arabia Inflammatory Bowel Disease (IBD) Treatment Revenue and Growth Rate (2015-2020)
9.3 UAE Inflammatory Bowel Disease (IBD) Treatment Revenue and Growth Rate (2015-2020)
9.4 Egypt Inflammatory Bowel Disease (IBD) Treatment Revenue and Growth Rate (2015-2020)
9.5 South Africa Inflammatory Bowel Disease (IBD) Treatment Revenue and Growth Rate (2015-2020)
10 Market Size Segment by Type
10.1 Global Inflammatory Bowel Disease (IBD) Treatment Revenue and Market Share by Type (2015-2020)
10.2 Global Inflammatory Bowel Disease (IBD) Treatment Market Forecast by Type (2019-2024)
10.3 TNF Inhibitors Revenue Growth Rate (2015-2025)
10.4 Aminosalicyclates Revenue Growth Rate (2015-2025)
10.5 Immunomodulators Revenue Growth Rate (2015-2025)
10.6 Corticosteroids Revenue Growth Rate (2015-2025)
11 Global Inflammatory Bowel Disease (IBD) Treatment Market Segment by Application
11.1 Global Inflammatory Bowel Disease (IBD) Treatment Revenue Market Share by Application (2015-2020)
11.2 Inflammatory Bowel Disease (IBD) Treatment Market Forecast by Application (2019-2024)
11.3 Hospital Pharmacy Revenue Growth (2015-2020)
11.4 Retail Pharmacy Revenue Growth (2015-2020)
11.5 Online Pharmacy Revenue Growth (2015-2020)
12 Global Inflammatory Bowel Disease (IBD) Treatment Market Size Forecast (2021-2025)
12.1 Global Inflammatory Bowel Disease (IBD) Treatment Market Size Forecast (2021-2025)
12.2 Global Inflammatory Bowel Disease (IBD) Treatment Market Forecast by Regions (2021-2025)
12.3 North America Inflammatory Bowel Disease (IBD) Treatment Revenue Market Forecast (2021-2025)
12.4 Europe Inflammatory Bowel Disease (IBD) Treatment Revenue Market Forecast (2021-2025)
12.5 Asia-Pacific Inflammatory Bowel Disease (IBD) Treatment Revenue Market Forecast (2021-2025)
12.6 South America Inflammatory Bowel Disease (IBD) Treatment Revenue Market Forecast (2021-2025)
12.7 Middle East & Africa Inflammatory Bowel Disease (IBD) Treatment Revenue Market Forecast (2021-2025)
13 Research Findings and Conclusion
14 Appendix
14.1 Methodology
14.2 Data Source
14.3 Disclaimer
14.4 About US
Table 1. Global Inflammatory Bowel Disease (IBD) Treatment Revenue (USD Million) by Type: 2015 VS 2019 VS 2025
Table 2. Breakdown of Inflammatory Bowel Disease (IBD) Treatment by Company Type (Tier 1, Tier 2 and Tier 3)
Table 3. Global Inflammatory Bowel Disease (IBD) Treatment Revenue (USD Million) by Application: 2015 VS 2019 VS 2025
Table 4. Global Market Inflammatory Bowel Disease (IBD) Treatment Revenue (Million USD) Comparison by Regions 2015-2025
Table 5. AbbVie Corporate Information, Location and Competitors
Table 6. AbbVie Inflammatory Bowel Disease (IBD) Treatment Major Business
Table 7. AbbVie Inflammatory Bowel Disease (IBD) Treatment Total Revenue (USD Million) (2017-2018)
Table 8. AbbVie SWOT Analysis
Table 9. AbbVie Inflammatory Bowel Disease (IBD) Treatment Product and Solutions
Table 10. AbbVie Inflammatory Bowel Disease (IBD) Treatment Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 11. Novartis Corporate Information, Location and Competitors
Table 12. Novartis Inflammatory Bowel Disease (IBD) Treatment Major Business
Table 13. Novartis Inflammatory Bowel Disease (IBD) Treatment Total Revenue (USD Million) (2018-2019)
Table 14. Novartis SWOT Analysis
Table 15. Novartis Inflammatory Bowel Disease (IBD) Treatment Product and Solutions
Table 16. Novartis Inflammatory Bowel Disease (IBD) Treatment Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 17. Janssen Biotech, Inc. (Johnson & Johnson) Corporate Information, Location and Competitors
Table 18. Janssen Biotech, Inc. (Johnson & Johnson) Inflammatory Bowel Disease (IBD) Treatment Major Business
Table 19. Janssen Biotech, Inc. (Johnson & Johnson) Inflammatory Bowel Disease (IBD) Treatment Total Revenue (USD Million) (2017-2018)
Table 20. Janssen Biotech, Inc. (Johnson & Johnson) SWOT Analysis
Table 21. Janssen Biotech, Inc. (Johnson & Johnson) Inflammatory Bowel Disease (IBD) Treatment Product and Solutions
Table 22. Janssen Biotech, Inc. (Johnson & Johnson) Inflammatory Bowel Disease (IBD) Treatment Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 23. Pfizer Corporate Information, Location and Competitors
Table 24. Pfizer Inflammatory Bowel Disease (IBD) Treatment Major Business
Table 25. Pfizer Inflammatory Bowel Disease (IBD) Treatment Total Revenue (USD Million) (2017-2018)
Table 26. Pfizer SWOT Analysis
Table 27. Pfizer Inflammatory Bowel Disease (IBD) Treatment Product and Solutions
Table 28. Pfizer Inflammatory Bowel Disease (IBD) Treatment Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 29. Takeda Pharmaceutical Corporate Information, Location and Competitors
Table 30. Takeda Pharmaceutical Inflammatory Bowel Disease (IBD) Treatment Major Business
Table 31. Takeda Pharmaceutical Inflammatory Bowel Disease (IBD) Treatment Total Revenue (USD Million) (2017-2018)
Table 32. Takeda Pharmaceutical SWOT Analysis
Table 33. Takeda Pharmaceutical Inflammatory Bowel Disease (IBD) Treatment Product and Solutions
Table 34. Takeda Pharmaceutical Inflammatory Bowel Disease (IBD) Treatment Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 35. Takeda Corporate Information, Location and Competitors
Table 36. Takeda Inflammatory Bowel Disease (IBD) Treatment Major Business
Table 37. Takeda Inflammatory Bowel Disease (IBD) Treatment Total Revenue (USD Million) (2017-2018)
Table 38. Takeda SWOT Analysis
Table 39. Takeda Inflammatory Bowel Disease (IBD) Treatment Product and Solutions
Table 40. Takeda Inflammatory Bowel Disease (IBD) Treatment Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 41. Bausch Health Corporate Information, Location and Competitors
Table 42. Bausch Health Inflammatory Bowel Disease (IBD) Treatment Major Business
Table 43. Bausch Health Inflammatory Bowel Disease (IBD) Treatment Total Revenue (USD Million) (2017-2018)
Table 44. Bausch Health SWOT Analysis
Table 45. Bausch Health Inflammatory Bowel Disease (IBD) Treatment Product and Solutions
Table 46. Bausch Health Inflammatory Bowel Disease (IBD) Treatment Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 47. Allergan Corporate Information, Location and Competitors
Table 48. Allergan Inflammatory Bowel Disease (IBD) Treatment Major Business
Table 49. Allergan Inflammatory Bowel Disease (IBD) Treatment Total Revenue (USD Million) (2017-2018)
Table 50. Allergan SWOT Analysis
Table 51. Allergan Inflammatory Bowel Disease (IBD) Treatment Product and Solutions
Table 52. Allergan Inflammatory Bowel Disease (IBD) Treatment Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 53. Biogen Inc. Corporate Information, Location and Competitors
Table 54. Biogen Inc. Inflammatory Bowel Disease (IBD) Treatment Major Business
Table 55. Biogen Inc. Inflammatory Bowel Disease (IBD) Treatment Total Revenue (USD Million) (2017-2018)
Table 56. Biogen Inc. SWOT Analysis
Table 57. Biogen Inc. Inflammatory Bowel Disease (IBD) Treatment Product and Solutions
Table 58. Biogen Inc. Inflammatory Bowel Disease (IBD) Treatment Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 59. Global Inflammatory Bowel Disease (IBD) Treatment Revenue (Million USD) by Players (2015-2020)
Table 60. Global Inflammatory Bowel Disease (IBD) Treatment Revenue Share by Players (2015-2020)
Table 61. Global Inflammatory Bowel Disease (IBD) Treatment Revenue (Million USD) by Regions (2015-2020)
Table 62. Global Inflammatory Bowel Disease (IBD) Treatment Revenue Market Share by Regions (2015-2020)
Table 63. North America Inflammatory Bowel Disease (IBD) Treatment Revenue by Countries (2015-2020)
Table 64. North America Inflammatory Bowel Disease (IBD) Treatment Revenue Market Share by Countries (2015-2020)
Table 65. Europe Inflammatory Bowel Disease (IBD) Treatment Revenue (Million USD) by Countries (2015-2020)
Table 66. Asia-Pacific Inflammatory Bowel Disease (IBD) Treatment Revenue (Million USD) by Countries (2015-2020)
Table 67. South America Inflammatory Bowel Disease (IBD) Treatment Revenue by Countries (2015-2020)
Table 68. South America Inflammatory Bowel Disease (IBD) Treatment Revenue Market Share by Countries (2015-2020)
Table 69. Middle East and Africa Inflammatory Bowel Disease (IBD) Treatment Revenue (Million USD) by Countries (2015-2020)
Table 70. Middle East and Africa Inflammatory Bowel Disease (IBD) Treatment Revenue Market Share by Countries (2015-2020)
Table 71. Global Inflammatory Bowel Disease (IBD) Treatment Revenue (Million USD) by Type (2015-2020)
Table 72. Global Inflammatory Bowel Disease (IBD) Treatment Revenue Share by Type (2015-2020)
Table 73. Global Inflammatory Bowel Disease (IBD) Treatment Revenue Forecast by Type (2021-2025)
Table 74. Global Inflammatory Bowel Disease (IBD) Treatment Revenue by Application (2015-2020)
Table 75. Global Inflammatory Bowel Disease (IBD) Treatment Revenue Share by Application (2015-2020)
Table 76. Global Inflammatory Bowel Disease (IBD) Treatment Revenue Forecast by Application (2021-2025)
Table 77. Global Inflammatory Bowel Disease (IBD) Treatment Revenue (Million USD) Forecast by Regions (2021-2025)
List of Figures
Figure 1. Inflammatory Bowel Disease (IBD) Treatment Picture
Figure 2. Global Inflammatory Bowel Disease (IBD) Treatment Revenue Market Share by Type in 2019
Figure 3. TNF Inhibitors Picture
Figure 4. Aminosalicyclates Picture
Figure 5. Immunomodulators Picture
Figure 6. Corticosteroids Picture
Figure 7. Inflammatory Bowel Disease (IBD) Treatment Revenue Market Share by Application in 2019
Figure 8. Hospital Pharmacy Picture
Figure 9. Retail Pharmacy Picture
Figure 10. Online Pharmacy Picture
Figure 11. Global Inflammatory Bowel Disease (IBD) Treatment Revenue (USD Million) and Growth Rate (2015-2025)
Figure 12. North America Inflammatory Bowel Disease (IBD) Treatment Revenue (Million USD) and Growth Rate (2015-2025)
Figure 13. Europe Inflammatory Bowel Disease (IBD) Treatment Revenue (Million USD) and Growth Rate (2015-2025)
Figure 14. Asia-Pacific Inflammatory Bowel Disease (IBD) Treatment Revenue (Million USD) and Growth Rate (2015-2025)
Figure 15. South America Inflammatory Bowel Disease (IBD) Treatment Revenue (Million USD) and Growth Rate (2015-2025)
Figure 16. Middle East and Africa Inflammatory Bowel Disease (IBD) Treatment Revenue (Million USD) and Growth Rate (2015-2025)
Figure 17. Global Inflammatory Bowel Disease (IBD) Treatment Revenue (Million USD) and Growth Rate (2015-2025)
Figure 18. Global Inflammatory Bowel Disease (IBD) Treatment Revenue Share by Players in 2019
Figure 19. Global Top 5 Players Inflammatory Bowel Disease (IBD) Treatment Revenue Market Share in 2019
Figure 20. Global Top 10 Players Inflammatory Bowel Disease (IBD) Treatment Revenue Market Share in 2019
Figure 21. Key Players Market Share Trend
Figure 22. Global Inflammatory Bowel Disease (IBD) Treatment Revenue (Million USD) and Growth Rate (%) (2015-2020)
Figure 23. Global Inflammatory Bowel Disease (IBD) Treatment Revenue Market Share by Regions (2015-2020)
Figure 24. Global Inflammatory Bowel Disease (IBD) Treatment Revenue Market Share by Regions in 2018
Figure 25. North America Inflammatory Bowel Disease (IBD) Treatment Revenue and Growth Rate (2015-2020)
Figure 26. Europe Inflammatory Bowel Disease (IBD) Treatment Revenue and Growth Rate (2015-2020)
Figure 27. Asia-Pacific Inflammatory Bowel Disease (IBD) Treatment Revenue and Growth Rate (2015-2020)
Figure 28. South America Inflammatory Bowel Disease (IBD) Treatment Revenue and Growth Rate (2015-2020)
Figure 29. Middle East and Africa Inflammatory Bowel Disease (IBD) Treatment Revenue and Growth Rate (2015-2020)
Figure 30. North America Inflammatory Bowel Disease (IBD) Treatment Revenue Market Share by Countries (2015-2020)
Figure 31. North America Inflammatory Bowel Disease (IBD) Treatment Revenue Market Share by Countries in 2019
Figure 32. USA Inflammatory Bowel Disease (IBD) Treatment Revenue and Growth Rate (2015-2020)
Figure 33. Canada Inflammatory Bowel Disease (IBD) Treatment Revenue and Growth Rate (2015-2020)
Figure 34. Mexico Inflammatory Bowel Disease (IBD) Treatment Revenue and Growth Rate (2015-2020)
Figure 35. Europe Inflammatory Bowel Disease (IBD) Treatment Revenue Market Share by Countries (2015-2020)
Figure 36. Europe Inflammatory Bowel Disease (IBD) Treatment Revenue Market Share by Countries in 2019
Figure 37. Germany Inflammatory Bowel Disease (IBD) Treatment Revenue and Growth Rate (2015-2020)
Figure 38. UK Inflammatory Bowel Disease (IBD) Treatment Revenue and Growth Rate (2015-2020)
Figure 39. France Inflammatory Bowel Disease (IBD) Treatment Revenue and Growth Rate (2015-2020)
Figure 40. Russia Inflammatory Bowel Disease (IBD) Treatment Revenue and Growth Rate (2015-2020)
Figure 41. Italy Inflammatory Bowel Disease (IBD) Treatment Revenue and Growth Rate (2015-2020)
Figure 42. Asia-Pacific Inflammatory Bowel Disease (IBD) Treatment Revenue Market Share by Countries (2015-2020)
Figure 43. Asia-Pacific Inflammatory Bowel Disease (IBD) Treatment Revenue Market Share by Countries in 2019
Figure 44. China Inflammatory Bowel Disease (IBD) Treatment Revenue and Growth Rate (2015-2020)
Figure 45. Japan Inflammatory Bowel Disease (IBD) Treatment Revenue and Growth Rate (2015-2020)
Figure 46. Korea Inflammatory Bowel Disease (IBD) Treatment Revenue and Growth Rate (2015-2020)
Figure 47. India Inflammatory Bowel Disease (IBD) Treatment Revenue and Growth Rate (2015-2020)
Figure 48. Southeast Asia Inflammatory Bowel Disease (IBD) Treatment Revenue and Growth Rate (2015-2020)
Figure 49. South America Inflammatory Bowel Disease (IBD) Treatment Revenue Market Share by Countries (2015-2020)
Figure 50. South America Inflammatory Bowel Disease (IBD) Treatment Revenue Market Share by Countries in 2019
Figure 51. Brazil Inflammatory Bowel Disease (IBD) Treatment Revenue and Growth Rate (2015-2020)
Figure 52. Argentina Inflammatory Bowel Disease (IBD) Treatment Revenue and Growth Rate (2015-2020)
Figure 53. Middle East and Africa Inflammatory Bowel Disease (IBD) Treatment Revenue Market Share by Countries (2015-2020)
Figure 54. Middle East and Africa Inflammatory Bowel Disease (IBD) Treatment Revenue Market Share by Countries in 2019
Figure 55. Saudi Arabia Inflammatory Bowel Disease (IBD) Treatment Revenue and Growth Rate (2015-2020)
Figure 56. UAE Inflammatory Bowel Disease (IBD) Treatment Revenue and Growth Rate (2015-2020)
Figure 57. Egypt Inflammatory Bowel Disease (IBD) Treatment Revenue and Growth Rate (2015-2020)
Figure 58. South Africa Inflammatory Bowel Disease (IBD) Treatment Revenue and Growth Rate (2015-2020)
Figure 59. Global Inflammatory Bowel Disease (IBD) Treatment Revenue Share by Type (2015-2020)
Figure 60. Global Inflammatory Bowel Disease (IBD) Treatment Revenue Share by Type in 2019
Figure 61. Global Inflammatory Bowel Disease (IBD) Treatment Market Share Forecast by Type (2021-2025)
Figure 62. Global TNF Inhibitors Revenue Growth Rate (2015-2020)
Figure 63. Global Aminosalicyclates Revenue Growth Rate (2015-2020)
Figure 64. Global Immunomodulators Revenue Growth Rate (2015-2020)
Figure 65. Global Corticosteroids Revenue Growth Rate (2015-2020)
Figure 66. Global Inflammatory Bowel Disease (IBD) Treatment Revenue Share by Application (2015-2020)
Figure 67. Global Inflammatory Bowel Disease (IBD) Treatment Revenue Share by Application in 2019
Figure 68. Global Inflammatory Bowel Disease (IBD) Treatment Market Share Forecast by Application (2021-2025)
Figure 69. Global Hospital Pharmacy Revenue Growth Rate (2015-2020)
Figure 70. Global Retail Pharmacy Revenue Growth Rate (2015-2020)
Figure 71. Global Online Pharmacy Revenue Growth Rate (2015-2020)
Figure 72. Global Inflammatory Bowel Disease (IBD) Treatment Revenue (Million USD) and Growth Rate Forecast (2021-2025)
Figure 73. Global Inflammatory Bowel Disease (IBD) Treatment Revenue (Million USD) Forecast by Regions (2021-2025)
Figure 74. Global Inflammatory Bowel Disease (IBD) Treatment Revenue Market Share Forecast by Regions (2021-2025)
Figure 75. North America Inflammatory Bowel Disease (IBD) Treatment Revenue Market Forecast (2021-2025)
Figure 76. Europe Inflammatory Bowel Disease (IBD) Treatment Revenue Market Forecast (2021-2025)
Figure 77. Asia-Pacific Inflammatory Bowel Disease (IBD) Treatment Revenue Market Forecast (2021-2025)
Figure 78. South America Inflammatory Bowel Disease (IBD) Treatment Revenue Market Forecast (2021-2025)
Figure 79. Middle East and Africa Inflammatory Bowel Disease (IBD) Treatment Revenue Market Forecast (2021-2025)
Figure 80. Sales Channel: Direct Channel vs Indirect Channel
炎症性心疾患の世界市場2020年：企業別、地域別、種類・用途別 Market Overview The global Inflammatory Heart Disease market size is expected to gain market growth in the forecast period of 2020 to 2025, with a CAGR of xx% in the forecast period of 2020 to 2025 and will expected to reach USD xx million by 2025, from USD xx million in 2019. The Inflammatory Heart…- ニューカッスル病治療薬の世界市場2020年：企業別、地域別、種類・用途別 Market Overview The global Newcastle Disease Treatment market size is expected to gain market growth in the forecast period of 2020 to 2025, with a CAGR of xx% in the forecast period of 2020 to 2025 and will expected to reach USD xx million by 2025, from USD xx million in 2019. The Newcastle Disease…
- 感染症治療の世界市場2020年：企業別、地域別、種類・用途別 Market Overview The global Infectious Disease Treatment market size is expected to gain market growth in the forecast period of 2020 to 2025, with a CAGR of 5.1% in the forecast period of 2020 to 2025 and will expected to reach USD 59530 million by 2025, from USD 48760 million in 2019. The Infectiou…
- ブタ呼吸器疾患治療の世界市場2020年：企業別、地域別、種類・用途別 Market Overview The Swine Respiratory Disease Treatment market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain…
- ICAD（頭蓋内アテローム性動脈硬化症）病理治療の世界市場2020年：企業別、地域別、種類・用途別 Market Overview The ICAD (Intracranial Atherosclerotic Disease) Pathology Treatment market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global…